Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and ...

HIV and AIDS (acquired immunodeficiency syndrome) surveillance has shown that Filipinos who are newly diagnosed with HIV are getting younger. The DOH noted that the predominant age group has shifted ...

HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the young. New research reveals older adults face comparable or higher ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

Globally, Montaner said, it is estimated American funding cuts will lead to another 6.6 million new HIV infections and an additional 4.2 million AIDS-related deaths between 2025 and 2029.

FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If approved, the shot—lenacapavir—would be given twice a year and ...

The first cases of HIV in the U.S. were reported on June 5, 1981. HIV is a virus that attacks a person's immune system, making them vulnerable to disease.

HIV's route to infection is more flexible than previously believed, study finds by Emily Kagey, Morgan Sherburne, University of Michigan edited by Lisa Lock, reviewed by Robert Egan Editors' notes ...

People have to test negative for HIV before they can receive the shot, which is administered under the skin of the abdomen. There are an estimated 30,000 new HIV infections in the U.S. annually.